Switching CF patients from previous pancreatic enzyme replacement therapy to ZENPEP™ (pancrelipase delayed-release capsules) improves symptom control of exocrine pancreatic insufficiency (EPI)
J.E. Heubi, C. Straforini, R. Thieroff-EkerdtVolume:
9
Year:
2010
Language:
english
DOI:
10.1016/s1569-1993(10)60299-8
File:
PDF, 50 KB
english, 2010